Human Adipose Tissue‐Derived Mesenchymal Stem Cells Abrogate Plasmablast Formation and Induce Regulatory B Cells Independently of T Helper Cells. (17th February 2015)
- Record Type:
- Journal Article
- Title:
- Human Adipose Tissue‐Derived Mesenchymal Stem Cells Abrogate Plasmablast Formation and Induce Regulatory B Cells Independently of T Helper Cells. (17th February 2015)
- Main Title:
- Human Adipose Tissue‐Derived Mesenchymal Stem Cells Abrogate Plasmablast Formation and Induce Regulatory B Cells Independently of T Helper Cells
- Authors:
- Franquesa, M.
Mensah, F. K.
Huizinga, R.
Strini, T.
Boon, L.
Lombardo, E.
DelaRosa, O.
Laman, J. D.
Grinyó, J. M.
Weimar, W.
Betjes, M. G. H.
Baan, C. C.
Hoogduijn, M. J. - Abstract:
- Abstract: Mesenchymal or stromal stem cells (MSC) interact with cells of the immune system in multiple ways. Modulation of the immune system by MSC is believed to be a therapeutic option for autoimmune disease and transplant rejection. In recent years, B cells have moved into the focus of the attention as targets for the treatment of immune disorders. Current B‐cell targeting treatment is based on the indiscriminate depletion of B cells. The aim of this study was to examine whether human adipose tissue‐derived MSC (ASC) interact with B cells to affect their proliferation, differentiation, and immune function. ASC supported the survival of quiescent B cells predominantly via contact‐dependent mechanisms. Coculture of B cells with activated T helper cells led to proliferation and differentiation of B cells into CD19 + CD27 high CD38 high antibody‐producing plasmablasts. ASC inhibited the proliferation of B cells and this effect was dependent on the presence of T cells. In contrast, ASC directly targeted B‐cell differentiation, independently of T cells. In the presence of ASC, plasmablast formation was reduced and IL‐10‐producing CD19 + CD24 high CD38 high B cells, known as regulatory B cells, were induced. These results demonstrate that ASC affect B cell biology in vitro, suggesting that they can be a tool for the modulation of the B‐cell response in immune disease. Stem Cells 2015;33:880–891
- Is Part Of:
- Stem cells. Volume 33:Number 3(2015:Mar.)
- Journal:
- Stem cells
- Issue:
- Volume 33:Number 3(2015:Mar.)
- Issue Display:
- Volume 33, Issue 3 (2015)
- Year:
- 2015
- Volume:
- 33
- Issue:
- 3
- Issue Sort Value:
- 2015-0033-0003-0000
- Page Start:
- 880
- Page End:
- 891
- Publication Date:
- 2015-02-17
- Subjects:
- B cell -- Immunomodulation -- Mesenchymal stem cell -- Plasmablast -- Regulatory B cell (Breg)
Cloning -- Periodicals
Clone cells -- Periodicals
Stem cells -- Periodicals
Cell Differentiation -- Periodicals
Cell Division -- Periodicals
Clone Cells -- Periodicals
Hematopoietic Stem Cells -- Periodicals
Stem Cells -- Periodicals
571.84 - Journal URLs:
- https://academic.oup.com/stmcls ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/stem.1881 ↗
- Languages:
- English
- ISSNs:
- 1066-5099
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 8464.133510
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 20724.xml